• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK INC PERITONEAL DIALYSIS CATHETER SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK INC PERITONEAL DIALYSIS CATHETER SET Back to Search Results
Model Number N/A
Device Problem Partial Blockage (1065)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Type  malfunction  
Manufacturer Narrative
Date of event: jan2008 - feb2018.The device was reported to be a "7.5 fr pd catheter"; however, cook currently does not nor has previously ever manufactured a peritoneal dialysis catheter set in this size.Process of elimination was not able to associate this catheter with any of the other manufacturer devices used in this study.Additionally, the literature states "acute pd (apd) catheter (7.5, 8.5, and 9 fr; cook inc., in, usa)" were used, thus associating this device with cook and prompting this report.Clarification was requested but is unavailable.This report includes information known at this time.A follow-up report will be submitted should additional relevant information become available.
 
Event Description
It was reported to cook in a literature article titled "challenges of acute peritoneal dialysis in extremely-low-birth-weight infants: a retrospective cohort study" that peritoneal dialysis (pd) was performed on 12 extremely-low-birth-weight (elbw) infants with acute kidney injury (aki).Cook devices are believed to have been used on six of these patients.This report focuses on patient 12.Of the 12 selected patients, seven were male and five were female.The mean gestational ages and birth weights among the selected patients were reported to be (b)(6) weeks and (706.5 (± 220.5) grams.None of the infants had congenital defects of the genitourinary system.Using the neonatal kdigo aki classification, nine of the patients were classified as stage 3 while the remaining three were classified as stage 2.Two of the patients had aki due to multiple organ dysfunction syndrome (mods) after asphyxia in the delivery room.Two patients started treatment due to bilateral renal vein thrombosis.Ten of the patients were administered inotropes prior to their aki diagnosis.All patients were admitted to the user facility's nicu.Five had accompanying congenital heart disease and twin-to-twin transfusion.Specific patient details for these are unknown.The dialysis technique used was described to be the same for all patients.The catheters were inserted bedside as the patients did not have favorable conditions for transportation to the operating room.Under sterile conditions and using local anesthesia, 20-gauge guide needles were inserted at the counter-mcburney point ("the point over the left side of the abdomen that is one-third of the distance from the anterior superior iliac spine to the umbilicus") and were used to administer 3-5 ml of sterile saline.The insertion site of the catheter was checked via abdominal sonography prior to puncture.After the guide needle was inserted, contents of the syringe were assessed to "check for the presence of bowel injury".Following, an iv canula/pd catheter was inserted using a guide wire for peritoneal access.Four brands of catheters were used in this study, one being cook, prompting this report and the associated reports.Using simple x-ray, the location of the catheter tip was evaluated.The pf catheter tip "was placed in the lower portion of the pelvis".Pd was started immediately following catheter insertion.It was written that "dialysis solutions (hemosol or physioneal) were used at standard hydrous dextrose concentrations of 2.5 and 4.25% with osmolalities of 396 and 485mosm/l.To optimize ultrafiltration, the concentration of the dextrose in the dialysate was increased sequentially from 2.5 to 4.25% while monitoring the blood sugar level.Pd was started at a rate of 10 ml/kg, which was increased to 20¿ 30 ml/kg at 60¿120min/cycle continuing for 24 h; e.G.Starting with input time, 20-min dwell time, 10-min outflow, 30min in case of 60min)".The concentration of pd fluid was increased in four patients from 2.5% to 4.25% due to insufficient drainage, but was decreased in one patient from 4.25% to 2.5% due to hyperglycemia.The dwell time was set at a drainage period of 10min at this stage.Regarding changes in dwell time, it was written that "the initial pd cycle yielded an exchange inflow of 10 ml/kg for 10 min, a dwell time of 30 min, and a drain time of 20min.We adjusted the dwell time and dextrose concentration of the dialysis fluids according to ultrafiltration (uf)".All complications and patient outcomes were evaluated based on clinical manifestations as well as results of biochemistry/serology studies, simple x-rays, and echocardiography.Regarding overall results, it was written that "the average rate of reduction in the serum bun and cr levels during dialysis was 42.5% (range, 12¿64%) and 20.1% (range, 0¿70%), respectively.The sodium levels increased from 135.8 to 144.7mg/ml, and the potassium levels decreased from 6.8 to 5.0 mg/ml after 9.3 (±4.4) days".Patient 12 is the subject of this report.This patient was weaned from pd after their renal function improved with a negative net uf value.Their gestational age (weeks) was reported to be (b)(6).Their birth weight was 470 grams.Their cause of aki was reported to be sepsis with a 13-day onset.A 7.5 fr pd catheter was used on this patient with a dwell time of 70 minutes.The uf rate (ml/kg/h) was -0.12.Bun pre-/post-pd (mg/dl), cr pre-/post-pd (mg/dl), sodium pre-/post-pd (mg/dl), and potassium pre-/post-pd (mg/dl) values were reported to be 66/26, 2.92/.88, 151/142, and 9.7/6.Urine output pre-/post- pd (ml/kg/h) was 1.13/5.7.Complications included catheter obstruction.This patient was reported to have survived, completely recovering his renal function "as defined by normalization of the serum bun, cr, and electrolyte levels; thus, he did not require longterm rrt".Additional information regarding the patients, devices, and events, as well as clarification, was requested but is not available.All events associated with this literature are reported under patient identifiers: (b)(6).Noh, j., kim, c.Y., jung, e.Et al.Challenges of acute peritoneal dialysis in extremely-low-birth-weight infants: a retrospective cohort study.Bmc nephrol 21, 437 (2020).Https://doi.Org/10.1186/s12882-020-02092-1.
 
Event Description
No additional information regarding the patient and/or event has been received since the previous medwatch report was sent.
 
Manufacturer Narrative
Correction: this report is being sent to indicate the complaint event is not reportable.Upon completion of the investigation, this complaint was unable to be confirmed.The clinical article indicated that the complaint device was a 7.5 french catheter; however, cook inc.Has not sold a cook peritoneal dialysis catheter set in this size, indicating that the complaint device was not manufactured by cook.It is possible that the complaint device is manufactured by another manufacturer listed within the article.Should additional information confirming the device to be manufactured by cook be received, this event will be further investigated.This report is required by the fda under 21 cfr part 803.This report is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement made in it is intended to be an admission that any cook device is defective or malfunctioned; that a death or serious injury occurred; or that any cook device caused or contributed to; or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERITONEAL DIALYSIS CATHETER SET
Manufacturer (Section D)
COOK INC
750 daniels way
bloomington IN 47404
MDR Report Key11261941
MDR Text Key266019006
Report Number1820334-2021-00226
Device Sequence Number1
Product Code GBW
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,literature,other
Type of Report Initial,Followup
Report Date 06/21/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberN/A
Device Catalogue NumberUNKNOWN
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 01/19/2021
Initial Date FDA Received02/01/2021
Supplement Dates Manufacturer Received06/08/2021
Supplement Dates FDA Received06/21/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-